531 – 540 of 7608
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer
(
- Contribution to journal › Scientific review
-
Mark
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
(
- Contribution to journal › Article
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
(
- Contribution to journal › Article
-
Mark
Tetraploidization Increases the Motility and Invasiveness of Cancer Cells
(
- Contribution to journal › Article
-
Mark
Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment
(
- Contribution to journal › Scientific review
-
Mark
Effect of invitation letter in language of origin on screening attendance : Randomised controlled trial in BreastScreen Norway
(
- Contribution to journal › Article
-
Mark
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
(
- Contribution to journal › Article
-
Mark
Hallmark discoveries in the biology of Wilms tumour
2023) In Nature Reviews Urology(
- Contribution to journal › Scientific review
-
Mark
Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases : a multinational cohort study
(
- Contribution to journal › Article
-
Mark
Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer
(
- Contribution to journal › Article